Showing results (51-60 of 483) with videos related to
Sort By:
Pageof 49
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1983
[Short-term intensive chemotherapy (STIC) combined with intravenous hyperalimentation in advanced stomach cancer]M Maeta, S Koga, N Shimizu, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1988
[Clinical results and problems of total-body thermochemotherapy]M Maeta, S Koga, N Shimizu, et al.Nihon Geka Gakkai Zasshi|September 1, 1983
[Immunological significance of splenectomy in gastric cancer surgery. Production of immunosuppressive factor in the spleen]H Kanayama, M Oda, T Karino, et al.Cancer|March 15, 1987
Clinical evaluation of total-body hyperthermia combined with anticancer chemotherapy for far-advanced miscellaneous cancer in JapanM Maeta, S Koga, J Wada, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1984
[Serum levels of mitomycin C following a high-dose continuous hyperthermic peritoneal perfusion]R Hamazoe, S Koga, M Maeta, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1984
[Combination chemotherapy with neocarzinostatin(NCS), HCFU and picibanil(NHO therapy) for advanced carcinoma of the digestive system--a comparative study with NF, and NFO therapy]M Maeta, S Koga, T Yamane, et al.Langenbeck'S Archives of Surgery|December 29, 2000
Limited operation for patients with T1 esophageal cancerM Ikeguchi, M Maeta, N KaibaraSurgery Today|January 1, 1993
Patients with multiple primary gastric cancers tend to develop second primaries in organs other than the stomachN Kaibara, M Maeta, M IkeguchiInternational Journal of Oncology|April 30, 2011
Therapeutic value of intraperitoneal hyperthermic peritoneal perfusion for patients with gastric cancerM Ikeguchi, M Maeta, N KaibaraInternational Journal of Molecular Medicine|March 20, 2001
Bax expression as a prognostic marker of postoperative chemoradiotherapy for patients with esophageal cancerM Ikeguchi, M Maeta, N KaibaraPageof 49